Publication

Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases

Dhib-Jalbut, Suhayl
Arnold, Douglas L.
Cleveland, Don W.
Fisher, Marc
Friedlander, Robert M.
Mouradian, M. Maral
Przedborski, Serge
Trapp, Bruce D.
Wyss-Coray, Tony
Yong, V. Wee
Embargo Expiration Date
Abstract

Multiple sclerosis is considered a disease of myelin destruction; Parkinson's disease (PD), one of dopaminergic neuron depletion; ALS, a disease of motor neuron death; and Alzheimer's, a disease of plaques and tangles. Although these disorders differ in important ways, they also have common pathogenic features, including inflammation, genetic mutations, inappropriate protein aggregates (e.g., Lewy bodies, amyloid plaques), and biochemical defects leading to apoptosis, such as oxidative stress and mitochondrial dysfunction. In most disorders, it remains uncertain whether inflammation and protein aggregation are neurotoxic or neuroprotective. Elucidating the mechanisms that orchestrate neuronal diseases should facilitate development of neuroprotective and neurorestorative strategies.

Source

J Neuroimmunol. 2006 Jul;176(1-2):198-215.

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
PubMed ID
16983747
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
Distribution License